COMP <GO>
ALGN vs ZBH // RSI-14 & 200D SMA MOMENTUM
Align Technology Inc. (NASDAQ) VS. Zimmer Biomet Holdings Inc. (NYSE) • 15-METRIC TALLY: ALGN 5
— ZBH 9
▲ RSI-14 & 200D SMA MOMENTUM LEADER: ZBH
LAST: $149.89 (-2.48%) • MKT CAP: $10.92B
rsi-technicals
56.3
LAST: $94.52 (-3.03%) • MKT CAP: $18.59B
rsi-technicals
57.0
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALGN VS. ZBH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALGN | ZBH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 67.20% | 69.70% | -2.50 | ZBH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.10% | 4.60% | +6.50 | ALGN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 19.3x | -2.30 | ALGN | /valuation <GO> |
| Free Cash Flow Yield | 4.49% | 7.92% | -3.43 | ZBH | /fcf-yield <GO> |
| Operating Margin | 13.50% | 13.30% | +0.20 | ALGN | /operating-margins <GO> |
| Net Profit Margin | 10.20% | 8.60% | +1.60 | ALGN | /net-margins <GO> |
| Revenue Growth (YoY) | 0.90% | 7.20% | -6.30 | ZBH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.02% | -1.02 | ZBH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.62 | 2.42 | +2.20 | ALGN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | ZBH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 56.3 | 57.0 | -0.70 | ZBH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 1.02 | -0.12 | ZBH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.7x | 24.6x | +0.10 | ZBH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.92B | $18.59B | -$7.67B | ZBH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALGN REV | ZBH REV | ALGN GROSS % | ZBH GROSS % | ALGN FCF | ZBH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.03B | $8.23B | 67.2% | 69.7% | $490.8M | $1.47B |
| FY 2024 | $4.00B | $7.68B | 70.0% | 71.5% | $622.7M | $1.30B |
| FY 2023 | $3.86B | $7.39B | — | — | $612.0M | $1.25B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALGN // BETA 0.90
ZBH // BETA 1.02